Strategy
Many different research programs have previously been developed at the VU/VUmc campus. However, efforts to transcend the disciplinary boundaries, from physics via life sciences, and from there, all the way to medicine - and back - have been partially limited due to organizational boundaries. In the Neuroscience Campus Amsterdam we are trying to further resolve potential barriers. Hence we invest in 'building new bridges' between different neuroscience research domains by providing two strategies: a) concerted funding of research support facilities and investments in advanced technology programs in parallel to b) financial support for initiatives with the objective to 'explore' and 'execute' common research interests with a potential campus-wide impact. In addition valorization, technology transfer, fund-raising and European collaboration are being used as 'instruments' to strengthen our core business.
Patient-clinics and the Netherlands Twin Register
All research in the 'brain disease mechanisms' programs is aimed and integrated with our in-house patient clinics, notably the Alzheimer Center, the Multiple Sclerosis Center and the treatment of Depression in the GGZBA-clinic. Moreover, also nicotine- and alcohol-abuse data of our depressed patients is being analyzed in the Addictive Behavior Program. The link between attentive traits in human twins and those being observed in ADHD patients provide a strong translational program towards the understanding of attentive behavior, impulsivity and cognition in general.
More information
Valorization
Our campus is very keen on valorization-initiatives. Towards this end the Technology Transfer Office lends full support towards valorization initiatives. It is expected that the Neuroscience Campus Amsterdam will soon start a 'holding' BV, which will incorporate all initiatives being generated in our network organization, including Intellectual Property agreements, dedicated Patient Care, and Contract Research. We will execute acquisition strategies that will coagulate the conditional funding of our main stream research activities.
More information
